Cognitive dysfunction with tolterodine use.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 17689620.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This is the first case of a 65 year old healthy woman developing de novo mental confusion during treatment with 2 mg tolterodine twice daily. It is a rare complication of therapy for overactive bladder and resolved when dosage was reduced to 1 mg, although overactive bladder symptoms were still controlled.
Medical subject headings
- Benzhydryl Compounds
- Cognition Disorders
- Cresols
- Phenylpropanolamine
- Urinary Bladder, Overactive